Sanofi (SNY) Change in Cash (2013 - 2026)

Sanofi (SNY) has 10 years of Change in Cash data on file, last reported at -$2.5 billion in Q1 2026.

• Quarterly Change in Cash fell 527.59% year-over-year to -$2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.8 billion (up 143.22% YoY) and the FY2025 annual result came in at $251.4 million, up 118.54% from the prior year.
• Change in Cash declined to -$2.5 billion in Q1 2026 per SNY's latest filing, from $10.2 billion in the prior quarter.
• The five-year high for Change in Cash was $12.2 billion in Q3 2023, with the low at -$14.1 billion in Q2 2022.
• Average Change in Cash over 5 years is $2.9 billion, with a median of $4.3 billion recorded in 2023.
• Year-over-year, Change in Cash soared 853.0% in 2025 and slumped 527.59% in 2026.
• Sanofi's Change in Cash stood at $10.2 billion in 2022, then sank by 32.0% to $6.9 billion in 2023, then sank by 119.58% to -$1.4 billion in 2024, then soared by 853.0% to $10.2 billion in 2025, then slumped by 124.23% to -$2.5 billion in 2026.
• Business Quant data shows SNY's Change in Cash at -$2.5 billion in Q1 2026, $10.2 billion in Q4 2025, and $1.7 billion in Q3 2025.